Archive for the ‘medical device industry’ Category
Can Hospitals and Medical Device Companies Ever Be Friends?
Maybe. If conversations start with shared goals like reduced readmissions
“…days of relying on glossy brochures while hiding unpublished clinical data are fast disappearing.”
And so Suzanne Belinson, executive director at BlueCross BlueShield, took the medical device community to task at the recent LifeScience Alley annual meeting, at least as recorded in yesterday’s Star Tribune (“In era of growing risk, emphasis grows on medical device data,” by Joe Carlson). The sin of selling will no longer be tolerated and hard data trumps happy smiling faces, so don’t be coming round with your “marketing presentations” and corporate pens with clever logos.
We will not be swayed.
Actually, the days of relying on glossy brochures have been gone for decades (and perhaps such “reliance” existed only in the fever dreams of ad agency execs). Most physicians have long demanded data and journal articles, most company representatives knew this. Of course, baddies in the mix will always re-interpret data (published and unpublished) to fit their promises to sales managers or shareholders.
So…data it is.
And the bigger the better. That seems to be a theme everywhere these days, from politics to education to fast food. We are gonna get to the truth of things by sifting the data. Because data does not lie: especially if your group “lives and breathes data.”
Of course, there will always be persuasion. If not glossy brochures, then the recommendations of thought leaders or interpretations and caveats of naysayers. There will always be data sources we pay attention to and data sources we dismiss. But we’ll be the judges as we do the numbers.
Two things strike me:
- We (the big collective we, as in everybody) need to pay attention way more than we do today to do an adequate job on the numbers. Can we all dive into the data to properly satisfy ourselves? Not likely. Life is just too busy.
- There must be trust at some point. Even those doing the numbers need help doing the numbers. And so we come to trust the white-smocked number-keepers to tell the truth. Do we really have time to not trust?
Maybe this is a place for “both/and” not “either/or.”
Let’s do the numbers as best we can and learn to trust, too.
And here’s a step toward trust: reducing hospital readmissions together is one very obvious data point.
The ACA penalizes hospitals if too many patients “are readmitted with 30 days after being hospitalized and discharged.” As hospitals and medical device firms approach the same goal, each from their perspective, we’ll find that “sharing risk” is likely to cause each party to spill a bit more of what they know. It is the transparency we foster in our conversation, as we both move toward the same goal, that will build trust.
###
Image credit: Glen Stubbe via Star Tribune
Why Medical Device Twitter Feeds are Boring
It’s because monologue can be enforced. Dialogue cannot.
Twitter is all about the quick, personality-laden human voice. Twitter carries truncated thoughts by design—more like a human talk—one thought at a time.
Official medical device Twitter feeds are boring because the communicators behind those feeds are trussed and bound by legal and regulatory protocols. The feeds are boring because competing lawyers have police scanner-like attention for claims that fall outside of the FDA-vetted matrix. And those feeds are also boring because many of us are not in chronic pain, or worried about going through airport security with a defibrillator or insulin pump or mechanical heart valve. If we were, we might get those medical device tweets instantly on our smartphones and find them very interesting indeed.
I’m glad those tweets are boring. I hope they continue to bore many of us because we don’t need the product.
How could medical device tweets be more interesting? Clearly the human voice must be involved. When Omar Ishrak tweets (@MedtronicCEO), the tweets are at times more personal, like when his daughter runs a marathon:
But generally medical device tweets lack the sound of the human voice. They tend to sound like monologue-rich press releases:
https://twitter.com/MDT_Cardiac/status/518422795077042177
Some companies don’t even try:
Ok: SJM does tweet over here: https://twitter.com/SJM_Media
Granted, medical device firms will never sass it up like DiGiorno pizza
But surely as we move forward into deepening inter-connections between professionals and regular humans, every company must find a way to sound human or risk not being heard.
Maybe that means special release from the legal/regulatory straightjackets for certain chatty employee/storytellers. Let them tell their stories in ways that are unique to them while continually repeating “My Opinion Only.” Can medical device firms institute official unofficial-storytellers? People who claim nothing but that they work at the place and this is what they see?
That might result in fun tweets that gather an audience and endear a company to a larger public.
The era of siloed communication is fading quickly in the rear-view mirror.
###
We Landed a Medtech Account—Now What? 3 Understandings
Bollixed and castrated and then we begin
Advertising agencies and marketing firms are eager to land medical device accounts. These prestigious accounts are much desired and would seem to enlarge the status of an agency because of the exacting, rigorous work that helps the human condition. It doesn’t hurt that they seem to pay on time. But having worked with a number of ad agencies once they land such an account, there are a few common threads that surprise principals and employees:
- You’ll need experts: people who know how to work within a regulatory framework (“Claim this.” “Never claim that.”). People who know the words that soothe lawyers while still making sense to humans. And especially people who know their sinus node rhythm from their rhythm method. You will stay on message and every claim must be neatly tied to an article from a respected (first or second-tier) journal.
- Your creatives are (already) wringing their hands. That’s because creative solutions lie on the other side of a legal/regulatory/corporate culture grinder.
- Yes: the company has come to you for creative solutions.
- No: they cannot/will not back-off their own internal legal/regulatory controls. Their own internal machinery will bind and castrate many of those solutions you have used in the past. What a great beginning point!
- There will be rounds of changes. Many rounds. Way more than you are used to. Far more than you can reasonably put in your bid. They will seem…unmanageable. Taming revisions will take your best customer service manners and may take you deep into the internal relationship structure of the firm. But that is exactly the kind of partnering that is needed
If your agency can come to grips with these three understandings without imploding or driving sane people mad, you’ll begin to build a reservoir of expertise.
###
Image credit: Kirk Livingston
Are You In—Or Are You a Loser?
Is club membership really that critical to you?
Sometimes we observe similarities between work and church. Here’s a way work and church similarly lose momentum with every conversation: making club membership their most important feature.
At work VPs and managers and employees speak in Dilbertesque code. Acronyms are just the beginning. In the medical device world, there are shorthand words for landmark studies, shorthand words for device features and benefits, shorthand words for certain technological functions. Shorthand words for the management focus of the quarter. Unless you’ve been around the team for a time, you wouldn’t understand 60% of the conversation. That’s why advertising agencies routinely hire translators when they get projects with medical device firms—they just don’t get the gibberish these smart people are talking.
At church we put on holy language and use words that make us seem like we are in the know. We deliver these words calmly as if they were on our minds all the time. The language of doubt is mostly unwelcome in this setting—this is where the faithful come for their weekly booster shot. And so language becomes subterfuge.
The problem with insider language at work or church is that it sets up participants for failure again and again. In both settings, many of the folks in the conversation don’t understand the very words they are saying—and don’t even realize they don’t understand. Or maybe they realize it but the insider current is so strong they are afraid to admit their lack.
Plain speech is a subversive force. Not only does plain speech out those not in the know, it actually forces those who think they know to explain or realize they know less than they thought. Plain speech is a force for progress because it breaks down hidden barriers and destroys a primary rhetorical tool for those who want to sit on their knowledge and keep it for themselves and to protect their kingdom.
This is why…again…no question is a dumb question. The simplest questions often carry great power.
As organizations (like work and church) realize they need to evangelize and draw outsiders in as a matter of survival, insider language must die.
Insider language is dead!
Long live language!
###
Image Credit: Kirk Livingston
Today I’m Listening
What can you hear between the lines—and where will it take you?
I’ll start by listening to a set of phone conversations my medical device client fields constantly. I want to hear the questions. I want to hear the responses. But I especially want to hear the tone of the questions. I’m listening for urgency and for actual language used. I’ll write down the words and note the flow and capture quotes. These notes and my listening will guide the communication that takes place next.
I’ll spend the balance of the day listening between the lines for another client. But this time I’ll be listening to the text I am creating for them. And I’ll listen to the process they use to serve their customers. Listening and revising and re-jiggering and re-listening.
Listening is required to know where to go next
What—or who—are you listening to today?
###
Image credit: Kirk Livingston